Advertisement

Intraocular Lymphoma: A Posterior Uveitis Masquerade Syndrome

  • Brian K. Do
  • Jesse L. Berry
  • Damien C. Rodger
Chapter
Part of the Essentials in Ophthalmology book series (ESSENTIALS)

Abstract

Intraocular lymphoma is a known ocular masquerade syndrome due to its variable presentation that can simulate other forms of ocular inflammation. Ocular lymphomas, in general, are rare and diverse and are often confused with other diagnoses first. These include primary intraocular lymphoma or vitreoretinal lymphoma, which is a high-grade malignancy associated with primary CNS lymphoma, but also the more indolent uveal lymphoma and ocular adnexal lymphoma. The diagnosis of the disease is often difficult, as investigations and treatment for possible other causes of uveitis, retinitis, and generalized ocular inflammation are initially undertaken, prior to a diagnosis of lymphoma being entertained. Imaging findings in this disease can equally be very variable; however there are some general principles which may help guide the clinician to the correct diagnosis; these will be discussed in this chapter.

Keywords

Masquerade syndrome Lymphoma Imaging Intraocular lymphoma Vitreoretinal lymphoma Uveal lymphoma Fluorescein angiography Indocyanine green angiography Autofluorescence Ocular coherence tomography Ultrasonography 

Notes

Compliance with Ethical Requirements

Brian K. Do, Jesse L. Berry, and Damien C. Rodger declare that they have no financial conflicts of interest pertaining to the material presented here. No human or animal studies were carried out by the authors for this chapter for the material presented herein.

References

  1. 1.
    Fend F, Ferreri AJ, Coupland SE. How we diagnose and treat vitreoretinal lymphoma. Br J Haematol. 2016;173(5):680–92.CrossRefGoogle Scholar
  2. 2.
    Karimi M, Soheilian M, Kanavi MR. Bilateral primary intraocular lymphoma. J Ophthalmic Vis Res. 2011;6(4):344–7.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Salomão DR, Pulido JS, Johnston PB, et al. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma. JAMA Ophthalmol. 2013;131(9):1151–8.CrossRefGoogle Scholar
  4. 4.
    Verbraeken HE, Hanssens M, Priem H, et al. Ocular non-Hodgkin’s lymphoma: a clinical study of nine cases. Br J Ophthalmol. 1997;81(1):31–6.CrossRefGoogle Scholar
  5. 5.
    Kuker W, Nagele T, Korfel A, et al. Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neuro-Oncol. 2005;72(2):169–77.CrossRefGoogle Scholar
  6. 6.
    Coupland SE, Bechrakis NE, Anastassiou G, et al. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with masquerade syndrome. Graefes Arch Clin Exp Ophthalmol. 2003;241(10):860–70.CrossRefGoogle Scholar
  7. 7.
    Whitcup SM, Stark-Vancs V, Wittes RE, et al. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Arch Ophthalmol. 1997;115(9):1157–60.CrossRefGoogle Scholar
  8. 8.
    Chan CC, Whitcup SM, Solomon D, Nussenblatt RB. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol. 1995;120(5):671–3.CrossRefGoogle Scholar
  9. 9.
    Buggage RR, Velez G, Myers-Powell B, et al. Primary intraocular lymphoma with a low interleukin 10 to interleukin 6 ratio and heterogeneous IgH gene rearrangement. Arch Ophthalmol. 1999;117(9):1239–42.CrossRefGoogle Scholar
  10. 10.
    Kuo DE, Wei MM, Armbrust KR, et al. Gradient boosted decision tree classification of endophthalmitis versus uveitis and lymphoma from aqueous and vitreous IL-6 and IL-10 levels. J Ocul Pharmacol Ther. 2017;33(4):319–24.CrossRefGoogle Scholar
  11. 11.
    Eliott D, Rao PK. Surgical management of intraocular inflammation and infection. London: JP Medical; 2013.CrossRefGoogle Scholar
  12. 12.
    Cassoux N, Charlotte F, Rao NA, et al. Endoretinal biopsy in establishing the diagnosis of uveitis: a clinicopathologic report of three cases. Ocul Immunol Inflamm. 2005;13(1):79–83.CrossRefGoogle Scholar
  13. 13.
    Jahnke K, Thiel E, Abrey LE, et al. Diagnosis and management of primary intraocular lymphoma: an update. Clin Ophthalmol. 2007;1(3):247–58.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Cockerham GC, Hidayat AA, Bijwaard KE, Sheng ZM. Re-evaluation of “reactive lymphoid hyperplasia of the uvea”: an immunohistochemical and molecular analysis of 10 cases. Ophthalmology. 2000;107(1):151–8.CrossRefGoogle Scholar
  15. 15.
    Aronow ME, Singh AD. The use of imaging in the diagnosis and management of intraocular lymphoma. Int Ophthalmol Clin. 2012;52(4):199–208.CrossRefGoogle Scholar
  16. 16.
    Hoskin PJ, Kirkwood AA, Popova B, et al. 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial. Lancet Oncol. 2014;15(4):457–63.CrossRefGoogle Scholar
  17. 17.
    Verdijk RM. Lymphoproliferative tumors of the ocular adnexa. Asia Pac J Ophthalmol (Phila). 2017;6(2):132–42.CrossRefGoogle Scholar
  18. 18.
    Fuller ML, Sweetenham J, Schoenfield L, Singh AD. Uveal lymphoma: a variant of ocular adnexal lymphoma. Leuk Lymphoma. 2008;49(12):2393–7.CrossRefGoogle Scholar
  19. 19.
    Cassoux N, Merle-Beral H, Leblond V, et al. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm. 2000;8(4):243–50.CrossRefGoogle Scholar
  20. 20.
    Kimura K, Usui Y, Goto H. Japanese intraocular lymphoma study G. clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol. 2012;56(4):383–9.CrossRefGoogle Scholar
  21. 21.
    Fardeau C, Lee CP, Merle-Beral H, et al. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol. 2009;147(5):886–94. 94 e1.CrossRefGoogle Scholar
  22. 22.
    Chan C-C, Gonzales JA. Primary intraocular lymphoma. Hackensack: World Scientific; 2007. xv, 284 p.CrossRefGoogle Scholar
  23. 23.
    Coupland S. Uveal lymphoproliferative tumors. In: Singh AD, Damato B, Peer J, et al., editors. Clinical ophthalmic oncology. Philadelphia: Elsevier Inc.; 2007.Google Scholar
  24. 24.
    Mashayekhi A, Shukla SY, Shields JA, Shields CL. Choroidal lymphoma: clinical features and association with systemic lymphoma. Ophthalmology. 2014;121(1):342–51.CrossRefGoogle Scholar
  25. 25.
    Ciulla TA, Bains RA, Jakobiec FA, et al. Uveal lymphoid neoplasia: a clinical-pathologic correlation and review of the early form. Surv Ophthalmol. 1997;41(6):467–76.CrossRefGoogle Scholar
  26. 26.
    Coupland SE, Foss HD, Bechrakis NE, et al. Secondary ocular involvement in systemic “memory” B-cell lymphocytic leukemia. Ophthalmology. 2001;108(7):1289–95.CrossRefGoogle Scholar
  27. 27.
    Grossniklaus HE, Martin DF, Avery R, et al. Uveal lymphoid infiltration. Report of four cases and clinicopathologic review. Ophthalmology. 1998;105(7):1265–73.CrossRefGoogle Scholar
  28. 28.
    Hoang-Xuan T, Bodaghi B, Toublanc M, et al. Scleritis and mucosal-associated lymphoid tissue lymphoma: a new masquerade syndrome. Ophthalmology. 1996;103(4):631–5.CrossRefGoogle Scholar
  29. 29.
    Jakobiec FA, Sacks E, Kronish JW, et al. Multifocal static creamy choroidal infiltrates. An early sign of lymphoid neoplasia. Ophthalmology. 1987;94(4):397–406.CrossRefGoogle Scholar
  30. 30.
    Ryan SJ, Zimmerman LE, King FM. Reactive lymphoid hyperplasia. An unusual form of intraocular pseudotumor. Trans Am Acad Ophthalmol Otolaryngol. 1972;76(3):652–71.PubMedGoogle Scholar
  31. 31.
    Saga T, Ohno S, Matsuda H, et al. Ocular involvement by a peripheral T-cell lymphoma. Arch Ophthalmol. 1984;102(3):399–402.CrossRefGoogle Scholar
  32. 32.
    Sarraf D, Jain A, Dubovy S, et al. Mucosa-associated lymphoid tissue lymphoma with intraocular involvement. Retina. 2005;25(1):94–8.CrossRefGoogle Scholar
  33. 33.
    Ridley ME, McDonald HR, Sternberg P Jr, et al. Retinal manifestations of ocular lymphoma (reticulum cell sarcoma). Ophthalmology. 1992;99(7):1153–60. discussion 60-1.CrossRefGoogle Scholar
  34. 34.
    Lang GK, Surer JL, Green WR, et al. Ocular reticulum cell sarcoma. Clinicopathologic correlation of a case with multifocal lesions. Retina. 1985;5(2):79–86.CrossRefGoogle Scholar
  35. 35.
    Purvin V, Van Dyk HJ. Primary reticulum cell sarcoma of the brain presenting as steroid-responsive optic neuropathy. J Clin Neuroophthalmol. 1984;4(1):15–23.CrossRefGoogle Scholar
  36. 36.
    Shields CL, Bianciotto C, Pirondini C, et al. Autofluorescence of choroidal melanoma in 51 cases. Br J Ophthalmol. 2008;92(5):617–22.CrossRefGoogle Scholar
  37. 37.
    Ryan ME, Shantha JG, Grossniklaus HE, Yeh S. Secondary vitreoretinal lymphoma masquerading as acute retinal necrosis. Ophthalmic Surg Lasers Imaging Retina. 2015;46(10):1048–50.CrossRefGoogle Scholar
  38. 38.
    Sen HN, Bodaghi B, Hoang PL, Nussenblatt R. Primary intraocular lymphoma: diagnosis and differential diagnosis. Ocul Immunol Inflamm. 2009;17(3):133–41.CrossRefGoogle Scholar
  39. 39.
    Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology. 1999;106(9):1805–10.CrossRefGoogle Scholar
  40. 40.
    Desroches G, Abrams GW, Gass JD. Reactive lymphoid hyperplasia of the uvea. A case with ultrasonographic and computed tomographic studies. Arch Ophthalmol. 1983;101(5):725–8.CrossRefGoogle Scholar
  41. 41.
    Cheung MK, Martin DF, Chan CC, et al. Diagnosis of reactive lymphoid hyperplasia by chorioretinal biopsy. Am J Ophthalmol. 1994;118(4):457–62.CrossRefGoogle Scholar
  42. 42.
    Holz FG, Boehmer HV, Mechtersheimer G, et al. Uveal non-Hodgkin’s lymphoma with epibulbar extension simulating choroidal effusion syndrome. Retina. 1999;19(4):343–6.CrossRefGoogle Scholar
  43. 43.
    Casady M, Faia L, Nazemzadeh M, et al. Fundus autofluorescence patterns in primary intraocular lymphoma. Retina. 2014;34(2):366–72.CrossRefGoogle Scholar
  44. 44.
    Velez G, Chan CC, Csaky KG. Fluorescein angiographic findings in primary intraocular lymphoma. Retina. 2002;22(1):37–43.CrossRefGoogle Scholar
  45. 45.
    Gass JD. Fluorescein angiography. An aid in the differential diagnosis of intraocular tumors. Int Ophthalmol Clin. 1972;12(1):85–120.PubMedGoogle Scholar
  46. 46.
    Kirmani MH, Thomas EL, Rao NA, Laborde RP. Intraocular reticulum cell sarcoma: diagnosis by choroidal biopsy. Br J Ophthalmol. 1987;71(10):748–52.CrossRefGoogle Scholar
  47. 47.
    Ishida T, Ohno-Matsui K, Kaneko Y, et al. Fundus autofluorescence patterns in eyes with primary intraocular lymphoma. Retina. 2010;30(1):23–32.CrossRefGoogle Scholar
  48. 48.
    Aronow ME, Portell CA, Sweetenham JW, Singh AD. Uveal lymphoma: clinical features, diagnostic studies, treatment selection, and outcomes. Ophthalmology. 2014;121(1):334–41.CrossRefGoogle Scholar
  49. 49.
    Chan CC, Sauer TC. Ocular imaging in primary retinal lymphoma. Am J Ophthalmol. 2009;147(5):764–5.CrossRefGoogle Scholar
  50. 50.
    Lopez JS, Chan CC, Burnier M, et al. Immunohistochemistry findings in primary intraocular lymphoma. Am J Ophthalmol. 1991;112(4):472–4.CrossRefGoogle Scholar
  51. 51.
    Meleth AD, Sen HN. Use of fundus autofluorescence in the diagnosis and management of uveitis. Int Ophthalmol Clin. 2012;52(4):45–54.CrossRefGoogle Scholar
  52. 52.
    Davis JL. Intraocular lymphoma: a clinical perspective. Eye (Lond). 2013;27(2):153–62.CrossRefGoogle Scholar
  53. 53.
    Egawa M, Mitamura Y, Hayashi Y, et al. Changes of fundus autofluorescence and spectral-domain optical coherence tomographic findings after treatment of primary intraocular lymphoma. J Ophthalmic Inflamm Infect. 2014;4(1):7.CrossRefGoogle Scholar
  54. 54.
    Shields CL, Arepalli S, Pellegrini M, et al. Choroidal lymphoma shows calm, rippled, or undulating topography on enhanced depth imaging optical coherence tomography in 14 eyes. Retina. 2014;34(7):1347–53.CrossRefGoogle Scholar
  55. 55.
    Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146(4):496–500.CrossRefGoogle Scholar
  56. 56.
    Kiernan DF, Mieler WF, Hariprasad SM. Spectral-domain optical coherence tomography: a comparison of modern high-resolution retinal imaging systems. Am J Ophthalmol. 2010;149(1):18–31.CrossRefGoogle Scholar
  57. 57.
    Say EA, Shah SU, Ferenczy S, Shields CL. Optical coherence tomography of retinal and choroidal tumors. J Ophthalmol. 2012;2012:385058.PubMedGoogle Scholar
  58. 58.
    Shah SU, Kaliki S, Shields CL, et al. Enhanced depth imaging optical coherence tomography of choroidal nevus in 104 cases. Ophthalmology. 2012;119(5):1066–72.CrossRefGoogle Scholar
  59. 59.
    Shields CL, Kaliki S, Rojanaporn D, et al. Enhanced depth imaging optical coherence tomography of small choroidal melanoma: comparison with choroidal nevus. Arch Ophthalmol. 2012;130(7):850–6.CrossRefGoogle Scholar
  60. 60.
    Shields CL, Materin MA, Shields JA. Review of optical coherence tomography for intraocular tumors. Curr Opin Ophthalmol. 2005;16(3):141–54.CrossRefGoogle Scholar
  61. 61.
    Corriveau C, Easterbrook M, Payne D. Lymphoma simulating uveitis (masquerade syndrome). Can J Ophthalmol. 1986;21(4):144–9.PubMedGoogle Scholar
  62. 62.
    Grimm SA, McCannel CA, Omuro AM, et al. Primary CNS lymphoma with intraocular involvement: international PCNSL collaborative group report. Neurology. 2008;71(17):1355–60.CrossRefGoogle Scholar
  63. 63.
    Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology. 1993;100(9):1399–406.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Brian K. Do
    • 1
  • Jesse L. Berry
    • 1
    • 2
  • Damien C. Rodger
    • 3
  1. 1.USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Department of OphthalmologyLos AngelesUSA
  2. 2.Children’s Hospital Los Angeles, Keck School of Medicine of the University of Southern CaliforniaLos AngelesUSA
  3. 3.Department of Ophthalmology, Kaiser Permanente Los Angeles Medical CenterLos AngelesUSA

Personalised recommendations